English
Investors
Shareholders
EQT logo
About
Teams
Sustainability
Investments
Media
Current portfolio
FoRx Therapeutics
oRx Therapeutics focuses on drugging key molecular targets involved in the DNA Replication Stress as a new approach in the developments.
Sector
Healthcare
Country
Switzerland
Fund
LSP 6
Entry
2019
Web
forxtherapeutics.com
Sector
Healthcare
Country
Switzerland
Fund
LSP 6
Entry
2019
Web
forxtherapeutics.com
Investments
EQT logo